[company_age]7.0[/company_age][employees]2-10 employees[/employees][funding]Non equity assistance[/funding][description]Prometheus Srl is an innovative startup founded in 2017 that focuses on biotechnology and medical devices for regenerative medicine. Their flagship product, Ematik, is a personalized patch for treating skin wounds, created from the patient's own blood. This solution boasts a 50% reduction in healing time, with no side effects or scarring. Ematik is available in two formats: Ematik Ready, a manual kit, and Ematik Lab, a fully automated system that standardizes the process. Initially targeted towards the veterinary market, Prometheus is developing a human version, Ematik H, to address chronic wounds like bedsores and diabetic foot ulcers, a significant concern in healthcare. The company's dedication to personalized medicine and innovative solutions sets it apart in the regenerative medicine field.[/description][ps]Ematik: Personalized wound care patch created from the patient's own blood.[/ps]